搜尋結果
Here’s Why Ozempic And Mounjaro Rivals Won’t Topple Drugmakers Novo Nordisk And Eli Lilly ...
Forbes· 1 日前Being the first companies to bring GLP-1 drugs to market for obesity positions them well to mar ...
Cholesterol pills spark health scare in Japan after 2 die, over 100 in hospital
South China Morning Post· 2 日前The supplement’s maker, Kobayashi Pharmaceutical, sells a wide range of health products marketed through television adverts ...
Real Madrid’s April Reinforcement Has ‘Debut’ Date Set, Reports AS
Forbes· 15 小時前Anonymous sources at Real Madrid have told AS that the return of a formerly injured first team star is "imminent". Los Blancos ...
Council Post: 4 Steps For Effective Change Management
Forbes· 15 小時前Those organizations that adhere to a four-pronged change management structure and related ...
Tony Orlando On Shifting From Live Shows To Film And Theater & The Legacy Of ‘Tie A Yellow Ribbon’
Forbes· 7 日前Tony Orlando is much-loved for a string of hits like “Knock Three Times,” “Candida”, “He Don’t Love You,” and others, but ...
Why Independent Grocers Are Pushing For Better Antitrust Enforcement
Forbes· 2 日前The $1 trillion grocery industry has been at the epicenter of debates around supply chain ...
Saudi Arabia, Ronaldo And Perfume Labels: Soccer’s Money-Making Machine
Forbes· 7 日前Welcoming an array of high-profile soccer stars from abroad has helped Saudi Arabia exercise a ...
Japan health scare grows
The Standard· 1 日前Two deaths and more than 100 hospitalizations have been linked to a growing health scare in Japan around dietary supplements ...
Site Map - CNBC.com
CNBC· 21 小時前Site mapArticlesLast 7 DaysStock futures are little changed as S&P 500 gets set to close out the first quarter up 10%: Live ...
Site Map - CNBC.com
CNBC· 21 小時前Site mapArticlestodayIs it time for investors to hedge for a market decline? The pros share their views and strategiesJim ...